Microbiota-derived metabolites in colorectal cancer patients in preoperative period - Publication - Bridge of Knowledge

Your account

login

Search

Microbiota-derived metabolites in colorectal cancer patients in preoperative period

Abstract

Short-chain fat-ty acids (SCFAs) are microbial derived metabo-lites, which have multiple beneficial properties. The amount of SCFAs depends on several fac-tors, such as age, diet (mainly intake of dietary fiber), and overall health condition. The normal proportion between SCFAs is 3:1:1 for acetate, proprionate and butyrate, respectively. In col-orectal cancer (CRC) patients, microbiota alter-ations have been shown. Consequently, metab-olome within the gut might change to a large ex-tent. Therefore, the aim of this study was to anal-yse the content of SCFAs and the proportion be-tween SCFAs in the stool obtained from CRC pa-tients in preoperative period. PATIENTS AND METHODS: This study in-cluded 15 patients with CRC in preoperative pe-riod. The stool samples were taken and stored at -80°C in the Fahrenheit Biobank BBMRI.pl, Med-ical University of Gdansk, Poland. The analysis of SCFAs from stool samples was conducted by means of gas chromatography. RESULTS: This study included mainly males (66.67%, n=10). In all patients, there was abnor-mal proportion between SCFAs. The extreme-ly higher concentration of butyrate was noted in 2 samples (13.33%) compared to the rest of pa-tients. However, based on normal proportion be-tween SCFAs, the results <1 for butyrate were noted in 93.33% of patients. CONCLUSIONS: SCFAs pool is altered in CRC patients, among others characterized by low level of butyrate. It should be considered to administer butyrate supplementation to CRC pa-tients especially prior to surgery to support an appropriate preparation to this treatment.

Citations

  • 0

    CrossRef

  • 0

    Web of Science

  • 4

    Scopus

Authors (8)

Cite as

Full text

download paper
downloaded 10 times
Publication version
Accepted or Published Version
DOI:
Digital Object Identifier (open in new tab) 10.26355/eurrev_202302_31384
License
Creative Commons: CC-BY-NC-ND open in new tab

Keywords

Details

Category:
Articles
Type:
artykuły w czasopismach
Published in:
European Review for Medical and Pharmacological Sciences no. 27, pages 1443 - 1449,
ISSN: 1128-3602
Language:
English
Publication year:
2023
Bibliographic description:
Każmierczak-Siedlecka K., Skonieczna-Żydecka K., Palma J., Sobocki B. K., Świerblewski M., Siedlecka-Kroplewska K., Kalinowski L., Połom K.: Microbiota-derived metabolites in colorectal cancer patients in preoperative period// European Review for Medical and Pharmacological Sciences -, (2023),
DOI:
Digital Object Identifier (open in new tab) 10.26355/eurrev_202302_31384
Sources of funding:
  • This research was funded in part by the Polish Ministry of Education and Science, grants No. 10/E-389/SPUB/SP/2020 and DIR/WK/2017/01.
Verified by:
Gdańsk University of Technology

seen 13 times

Recommended for you

Postbiotics in oncology: science or science fiction?

  • A. Kudra,
  • K. Kaźmierczak-Siedlecka,
  • B. K. Sobocki
  • + 7 authors
2023

Maternal smoking Modulates Fatty Acid Profile of Breast Milk

2013

Chemical Characteristics and Thermal Oxidative Stability of Novel Cold-Pressed Oil Blends: GC, LF NMR, and DSC Studies

  • W. Cichocki,
  • D. Kmiecik,
  • H. M. Baranowska
  • + 3 authors
2023

Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?

  • K. Kaźmierczak-Siedlecka,
  • N. Bulman,
  • P. Ulasiński
  • + 5 authors
2023
Meta Tags